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Abstract
Chlorpromazine (CPZ), a widely used tranquilizer, is known to induce stomatocytic shape changes in human erythrocytes.
However, the effect of CPZ on membrane mechanical properties of erythrocyte membranes has not been documented. In the
present study we show that CPZ induces a dose-dependent increase in mechanical stability of erythrocyte ghost membrane.
Furthermore, we document that spectrin specifically binds to CPZ intercalated into inside-out vesicles depleted of all
peripheral proteins. These findings imply that CPZ-induced mechanical stabilization of the erythrocyte ghost membranes
may be mediated by direct binding of spectrin to the bilayer. Membrane active drugs that partition into lipid bilayer can thus
induce cytoskeletal protein interactions with the membrane and modulate membrane material properties. ß 2001 Published
by Elsevier Science B.V.
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1. Introduction
Chlorpromazine (CPZ) is widely used as a tran-
quilizer in the management of certain psychiatric dis-
orders. The amphipathic feature of CPZ enables it to
rapidly distribute itself into the lipid bilayer of bio-
logical membranes and in the case of human eryth-
rocytes induces morphologic transformation from a
normal biconcave disc to a stomatocytic form [1^6].
During passage through the microvasculature, the
circulating erythrocytes undergo extensive passive de-
formation and marked alterations in cell shape. This
entails the erythrocyte membrane to undergo large
extensional deformation without membrane fragmen-
tation. The unique mechanical features of human
erythrocytes, a readily deformable yet a mechanically
stable membrane, enable the erythrocyte to undergo
the required deformations without losing structural
integrity. The unique mechanical properties of the
erythrocyte membrane are primarily regulated by
the spectrin-based membrane skeleton that underlies
the lipid bilayer [7]. Marked extensibility of the spec-
trin lattice accounts for membrane deformability
while lateral interactions of spectrin with actin, pro-
tein 4.1R and adducin in the skeletal network are
responsible for maintaining membrane mechanical
stability. The spectrin-based network is anchored to
the bilayer through interactions with two transmem-
brane proteins, band 3 and glycophorin C [8,9], and
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these protein^protein interactions have recently been
shown to play a role in maintaining membrane me-
chanical stability [10,11]. Spectrin can also directly
interact with phosphatidylserine in the lipid bilayer
[12,13], but the role of this protein^lipid interaction
in regulating membrane mechanical properties has
not been elucidated. Furthermore, no information
is currently available on the potential interaction be-
tween bilayer intercalating drugs such as CPZ and
various membrane skeletal proteins and the e¡ects
of such interactions on membrane mechanical prop-
erties. In the present study, we examined whether
CPZ can a¡ect the mechanical properties of erythro-
cyte ghost membranes. We show that CPZ induces a
dose-dependent increase in membrane mechanical
stability. We further document that spectrin speci¢-
cally binds to CPZ intercalated into inside-out
vesicles depleted of all peripheral proteins. These
¢ndings imply that CPZ mechanically stabilizes er-
ythrocyte membranes by inducing binding of spectrin
to the bilayer. We have thus identi¢ed a novel role
for membrane active drugs that partition into lipid
bilayer in mediating cytoskeletal protein interactions
with the membrane and thereby modulating mem-
brane mechanical function.
2. Experimental procedures
2.1. Materials
A 10 mM stock solution of chlorpromazine hydro-
chloride (Wako Pure Chemical Industries) was pre-
pared in a medium containing 150 mM KCl, 1 mM
MgCl2 and 1 mM dithiothreitol adjusted to pH 6.9
using Tris and stored at 4‡C in the dark.
2.2. Preparation of erythrocyte ghosts
After obtaining informed consent, venous blood
was obtained from healthy volunteer donors. Eryth-
rocytes isolated from whole blood were washed three
times with Tris-bu¡ered wash solution (10 mM Tris,
120 mM KCl, pH 7.4). Intact erythrocytes were lysed
and washed three times in 35 vols. of hypotonic bu¡-
er (5 mM Tris, 5 mM KCl, pH 7.4) at 4‡C. The
resulting white ghost membranes were gently stirred
at 0‡C for 10 min in bu¡er A (150 mM KCl, 1 mM
MgCl2 and 1 mM dithiothreitol, pH 7.4) and subse-
quently incubated at 37‡C for 40 min to allow mem-
brane resealing [14]. Resealed ghosts were incubated
with various concentrations of CPZ at 0‡C for
10 min. The morphology of glutaraldehyde ¢xed re-
sealed ghosts was examined by dark-¢eld light mi-
croscopy using a Nikon microscope. At a CPZ con-
centration of 1.5 mM, approx. 100 nM of CPZ was
incorporated into 1 mg of ghost membranes.
2.3. Measurement of membrane mechanical properties
Resealed ghost preparations were resuspended in a
35% dextran solution and membrane deformability
was measured using an ektacytometer, as previously
described [14,15]. Brie£y, ghosts were subjected to
increasing levels of applied shear stress (0^150
dynes/cm2) and changes in the deformability index
(DI), a direct measure of cell ellipticity, was recorded
as a function of applied stress. The maximal value of
DI attained (DImax) is a measure of the surface area
of resealed ghosts while the initial slope of the DI
curve provides a measure of membrane deformabil-
ity. To determine membrane mechanical stability, re-
sealed ghosts suspended in a 50% dextran solution
were subjected to a constant applied shear stress of
750 dynes/cm2 in the ektacytometer. The rate of de-
crease of DI, a direct measure of the rate of mem-
brane fragmentation, provides a quantitative mea-
sure of membrane mechanical stability [16].
2.4. Measurement of membrane associated CPZ
To quantitate the amount of CPZ associated with
resealed membranes, ghosts incubated with 1.5 mM
CPZ were diluted with various volumes of bu¡er A.
The membrane suspension was centrifuged at
7500Ug for 10 min and the amount of CPZ in the
supernatants was quanti¢ed by HPLC using a 5C18-
MS Packed Column (Cosmosil). The amount of
ghost membrane associated CPZ was calculated by
subtracting the amount of CPZ in the supernatant
from the total amount of added CPZ.
2.5. Measurement of spectrin binding to CPZ-loaded
inside-out vesicles
Inside-out vesicles (IOV) depleted of all peripheral
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proteins including spectrin were prepared as de-
scribed by Danilov et al. [17]. Spectrin dimers were
puri¢ed from human erythrocytes as described by
Harris et al. [18]. IOVs at a protein concentration
of 0.83 mg/ml were incubated with various concen-
trations of CPZ at 0‡C for 10 min. Thereafter, sam-
ples containing 100 Wg of IOVs were incubated with
varying concentrations of spectrin dimers in 250 Wl of
bu¡er B (130 mM KCl, 20 mM NaCl, 1 mM MgCl2,
10 mM Tris/HCl, pH 7.4) at 24‡C for 1 h. Following
incubation, 200 Wl of the mixture was layered on
top of 200 Wl of 8% sucrose solution in bu¡er B
in a centrifuge tube. Following centrifugation at
35 000Ug at 4‡C for 40 min, the pelleted IOVs
were collected and their protein content analyzed
electrophoretically using 7.5% sodium dodecyl sul-
fate^polyacrylamide gels. Coomassie brilliant blue
stained gels were scanned using a densitometer (Flu-
or-S Multiimager, Bio-Rad) and the extent of spec-
trin associated with IOVs quantitated.
3. Results
3.1. E¡ect of CPZ on ghost morphology and
membrane deformability
To determine whether CPZ induces stomatocytic
shape changes in ghosts as it does in intact erythro-
cytes, we examined the morphology of CPZ-treated
ghosts. While control ghosts without CPZ were echi-
nocytic, the ghosts treated with increasing concentra-
tions of CPZ at 0‡C for 10 min became progressively
more stomatocytic (Fig. 1), implying that CPZ in-
duces similar morphological changes in ghosts as
has been previously reported for intact erythrocytes
[19,20]. Higher concentrations of CPZ were needed
to induce stomatocytic changes in ghosts compared
to discoid erythrocytes since an additional amount of
CPZ was needed to convert the initially echinocytic
ghosts into discoid shape before transformation into
stomatocytes. The e¡ect of CPZ on membrane de-
formability was assessed by ektacytometry (Fig. 2).
The deformability pro¢les of ghost membranes incu-
bated with CPZ at concentrations up to 1.5 mM
were very similar to that of control membranes re-
gardless of the extent of induced stomatocytic shape
changes. These ¢ndings imply that CPZ at concen-
trations up to 1.5 mM does not alter membrane de-
formability. However, treatment with higher CPZ
concentrations resulted in decreased DImax, indicat-
ing irreversible loss of functional surface area. This is
most likely the result of the generation of sphero-
stomatocytes with endovesicles. Similar e¡ects of
CPZ on loss of cellular deformability of intact eryth-
rocytes due to endocytosis at high concentrations
have previously been reported [21].
3.2. E¡ects of CPZ on ghost membrane mechanical
stability
Representative data from membrane mechanical
stability measurements on ghosts treated with vari-
ous concentrations of CPZ are shown in Fig. 3.
When the control ghosts were exposed to a shear
stress of 750 dynes/cm2, they rapidly reached their
maximum extent of deformation (a DI value of
0.82). However, with continued application of this
high level of shear stress, the ghosts began to frag-
ment resulting in progressive decrease of DI. The
rate of decline in DI is a direct measure of the rate
of membrane fragmentation. The rate of decline of
Fig. 1. E¡ects of CPZ on the shape of resealed ghosts. The
morphology of resealed ghosts incubated with 0 (A), 0.6 (B),
1.4 (C) and 2.1 (D) mM CPZ was observed as described in Sec-
tion 2. The bar indicates 10 Wm.
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DI for ghost membranes treated with CPZ at con-
centrations 6 0.8 mM was very similar to that of
control ghosts, indicating that CPZ at these concen-
trations has little e¡ect on ghost membrane mechan-
ical stability. However, at higher CPZ concentrations
there was a dose-dependent decrease in the rate of
DI decline, implying that CPZ at concentrations be-
tween 0.8 and 1.5 mM increases membrane mechan-
ical stability.
3.3. Reversible e¡ects of CPZ on membrane
mechanical stability
To con¢rm that the observed increase in mem-
brane mechanical stability is indeed due to CPZ in-
tercalating into the membrane, we explored the re-
versibility of the induced change following extraction
of CPZ from the membrane. Ghosts incubated with
1.5 mM CPZ were diluted with various volumes of
bu¡er A and the residual amount of CPZ associated
with the ghosts was quantitated. Representative data
for the distribution of CPZ between the supernatant
and the pellet in each sample following di¡erent di-
lutions are shown in Fig. 4A. With increasing dilu-
tion there is progressive decrease in the amount of
membrane associated CPZ. Following a 10-fold dilu-
tion, the amount of CPZ associated with membranes
decreased by 55%. In parallel, membrane mechanical
stability decreased reaching a level comparable to
that of untreated ghosts (Fig. 4B). These ¢ndings
imply that CPZ-induced changes in mechanical
stability are completely reversible.
3.4. E¡ects of CPZ on spectrin binding to IOVs
To investigate whether CPZ can mediate spectrin
binding to biological membranes, we quantitated
binding of puri¢ed spectrin to IOVs incubated with
various concentrations of CPZ (Fig. 5A). Control
IOVs and IOVs preloaded with CPZ at 0.8 mM or
Fig. 4. Extraction of CPZ from erythrocyte ghosts. (A) Ghosts
incubated with 1.5 mM CPZ were diluted with various volumes
of bu¡er A. The amount of CPZ distributed in the ghost mem-
branes was determined as described in Section 2. (B) Membrane
stability of samples shown in A were measured using an ektacy-
tometer (a, control ghosts without CPZ; b, ghosts incubated
with 1.5 mM CPZ; c, 1.5 mM CPZ-loaded ghosts following a
10-fold dilution with bu¡er A).
Fig. 3. E¡ects of CPZ on membrane mechanical stability. Mem-
brane stability of resealed ghosts incubated with various con-
centrations of CPZ was measured using an ektacytometer as de-
scribed in Section 2.
Fig. 2. E¡ects of CPZ on membrane deformability. Membrane
deformability of resealed ghosts incubated with various concen-
trations of CPZ was measured using an ektacytometer as de-
scribed in Section 2.
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less bound very little spectrin and the extent of bind-
ing did not increase with increasing concentrations of
added spectrin. Importantly, preloading of IOVs
with CPZ at concentrations greater than 0.8 mM
and up to 1.6 mM resulted in a marked increase in
the extent of spectrin binding. Spectin binding to
these IOVs was concentration dependent and satura-
ble. Scatchard analysis of spectrin binding to IOVs
preloaded with 1.6 mM CPZ (Fig. 5B) showed that
spectrin binds to CPZ with a moderately high a⁄nity
(Kd = 130 nM). Our calculations suggest that spectrin
interaction with the membrane occurs when 1000
CPZ molecules per spectrin dimer are loaded onto
the IOV membrane. In contrast to spectrin, CPZ
had no e¡ect on protein 4.1 or ankyrin binding to
IOVs (data not shown).
4. Discussion
The present study identi¢ed a novel e¡ect of CPZ
on the mechanical properties of erythrocyte ghost
membrane. Over a range of concentrations, CPZ in-
duced a dose-dependent increase in membrane me-
chanical stability with little e¡ect on membrane de-
formability. Importantly, the CPZ e¡ect on ghost
membrane stability was completely reversible. Pre-
vious studies [8,9] have shown that mechanical stabil-
ity of erythrocyte membranes is regulated by pro-
tein^protein interactions, lateral interactions of spec-
trin with other skeletal proteins, and by the vertical
interaction of spectrin with band 3 mediated by an-
kyrin. We have now been able to document that
spectrin association with lipid bilayer mediated by
CPZ can also regulate membrane mechanical stabil-
ity. These ¢ndings thus enabled the identi¢cation of
an important role for spectrin^lipid interaction in
modulating membrane function.
In the present study we obtained direct evidence
for spectrin interaction with CPZ intercalated into
the bilayer. Detailed analysis of the binding data
revealed that spectrin binds to CPZ with a moder-
ately high a⁄nity ^ Kd on the order of 100 nM. It is
interesting to note that the binding a⁄nity of spec-
trin to CPZ is very similar to the binding a⁄nity of
spectrin to ankyrin and to protein 4.1R. Previous
studies have shown that spectrin can bind to nega-
tively charged phospholipid, phosphatidylserine lo-
calized to the inner lea£et of the bilayer. The CPZ-
induced change in membrane stability we docu-
mented is unlikely to be the consequence of CPZ-
induced association of spectrin with phosphatidylser-
ine. This is because phosphatidylserine is scrambled
in the bilayer of ghosts prepared in the absence of
MgATP [22^24] and we have been able to document
that spectrin cannot bind to any signi¢cant extent to
IOVs in which phosphatidylserine was scrambled. It
should also be noted that CPZ itself has potential to
scramble lipid distribution in the bilayer [6,25,26].
More importantly, we have been able to document
that removal of CPZ from ghost membranes reversed
the induced e¡ects on membrane mechanical stabil-
ity. Thus the observed e¡ects can be attributed di-
rectly to interaction of the skeletal network with
CPZ in the lipid bilayer.
Human erythrocyte membranes constitute a useful
model to study the mechanism of drug action on
membranes. Spectrin analogues have been identi¢ed
in a variety of non-erythroid cells including various
cell types in the brain [27,28]. Although the tranquil-
izing e¡ect of CPZ is most likely the result of block-
ing the monoamine receptors of nerve cells [29,30],
the CPZ-induced association of spectrin-based mem-
brane skeleton with the plasma membrane of the
neuronal cells may represent an additional mecha-
nism of its action.
Fig. 5. E¡ects of CPZ on spectrin binding to IOV. (A) Spectrin
at various concentrations was incubated with IOV preloaded
with 0 (O), 0.4 (R), 0.8 (E), 1.0 (F), 1.5 (a), and 1.6 (b) mM
CPZ. The amount of spectrin bound to IOV was determined as
described in Section 2. (B) Scatchard analysis of the data de-
rived from incubation with 1.6 mM CPZ (A, b). The estimated
Kd value and binding capacity were 130 nM and 239 Wg/mg, re-
spectively.
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